Emerging data suggest Retatrutide , a dual stimulator targeting both GLP-1 and GIP , may offer a notable step forward for obesity treatment. Preliminary clinical trials have demonstrated considerable https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026